Hematology Analyzers And Reagents Market Scope And Analysis

  • Report Code : TIPRE00003261
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Hematology Analyzers And Reagents Market Scope and Key Players Analysis by 2031

Buy Now


Hematology Analyzers And Reagents Market Report Scope

Report Attribute Details
Market size in 2021 US$ 8.32 million
Market Size by 2031 US$ 18.20 million
Global CAGR (2023 - 2031) 8.4%
Historical Data 2021-2022
Forecast period 2023-2031
Segments Covered By Product and Service
  • Hematology Products and Services
  • Hemostasis Products and Services
  • Immunohematology Products and Services
By Application
  • Anemia
  • Blood Cancer
  • Hemorrhagic Conditions
  • Infection Related Conditions
  • Immune System Related Conditions
  • Applications
By End User
  • Hospital Laboratories
  • Commercial Service Providers
  • Government Reference Laboratories
  • Research and Academic Institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Clinical Diagnostic Solutions Inc
  • Shenzhen Mindray Bio Medical Electronics Co Ltd
  • Danaher
  • BIO RAD LABORATORIES INC
  • Abbott
  • Diatron
  • ERBA Diagnostics Inc
  • EKF Diagnostics
  • HORIBA Medical
  • Biosystems S A
  • Hematology Analyzers And Reagents Market News and Recent Developments

    The hematology analyzers and reagents market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for hematology analyzers and reagents and strategies:

    • HORIBA Medical launched new products in its Yumizen hematology product family. The company introduced two compact benchtop hematology analyzers, Yumizen H500 and Yumizen H550, which offer enhanced performance, new features, and increased benefits. These analyzers have been designed to deliver a rapid and comprehensive hematology report with a high throughput of 60 tests per hour, 40 tubes autonomy with continuous loading, urgent manual mode, and multi-analysis modes and sampling for running samples. (Source: HORIBA Medical, 2022)
    • Mindray launched a revolutionary hematology analyzer series, the BC-700 Series, which incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. The series includes two open vial models, BC-700/BC-720, and two autoloader models, BC-760/BC-780. This series is designed to empower medium-volume laboratories with advanced diagnostics technologies applied in premium products. (Source: Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Press Release, 2022)

    Hematology Analyzers And Reagents Market Report Coverage and Deliverables

    The “Hematology Analyzers And Reagents Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles